Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Transdermal Drug Patches market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period.
This report presents the market size and development trends by detailing the Transdermal Drug Patches market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Transdermal Drug Patches market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Transdermal Drug Patches industry and will help you to build a panoramic view of the industrial development.
Transdermal Drug Patches Market, By Type:
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Transdermal Drug Patches Market, By Application:
Used for Hypertension
Used for Contraception
Used for Analgesia
Used for Smoking Cessation
Used for Angina
Used for Hormone Replacement
Some of the leading players are as follows:
Noven
Mylan
Agile Therapeutics
Hercon Pharmaceuticals
Pocono
Johnson & Johnson
Teikoku Pharma USA
Immune Pharmaceuticals
Xel Pharmaceuticals
DURECT Corporation
Novartis
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Transdermal Drug Patches Market: Technology Type Analysis
-
4.1 Transdermal Drug Patches Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Transdermal Drug Patches Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Fentanyl Transdermal Patch
4.3.2 Nicotine Transdermal Patch
4.3.3 Buprenorphine Transdermal Patch
4.3.4 Clonidine Transdermal Patch
4.3.5 Oxybutynin Transdermal Patch
4.3.6 Others
5 Transdermal Drug Patches Market: Product Analysis
-
5.1 Transdermal Drug Patches Product Market Share Analysis, 2018 & 2026
-
5.2 Transdermal Drug Patches Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Transdermal Drug Patches Market: Application Analysis
-
6.1 Transdermal Drug Patches Application Market Share Analysis, 2018 & 2026
-
6.2 Transdermal Drug Patches Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Used for Hypertension
6.3.2 Used for Contraception
6.3.3 Used for Analgesia
6.3.4 Used for Smoking Cessation
6.3.5 Used for Angina
6.3.6 Used for Hormone Replacement
7 Transdermal Drug Patches Market: Regional Analysis
-
7.1 Transdermal Drug Patches Regional Market Share Analysis, 2018 & 2026
-
7.2 Transdermal Drug Patches Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Noven
9.1.1 Noven Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Mylan
9.2.1 Mylan Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Agile Therapeutics
9.3.1 Agile Therapeutics Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Hercon Pharmaceuticals
9.4.1 Hercon Pharmaceuticals Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Pocono
9.5.1 Pocono Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Johnson & Johnson
9.6.1 Johnson & Johnson Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Teikoku Pharma USA
9.7.1 Teikoku Pharma USA Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Immune Pharmaceuticals
9.8.1 Immune Pharmaceuticals Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Xel Pharmaceuticals
9.9.1 Xel Pharmaceuticals Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 DURECT Corporation
9.10.1 DURECT Corporation Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Novartis
9.11.1 Novartis Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 64 Figures and 125 Tables)
Figure Fentanyl Transdermal Patch Transdermal Drug Patches market, 2015 - 2026 (USD Million)
Figure Nicotine Transdermal Patch Transdermal Drug Patches market, 2015 - 2026 (USD Million)
Figure Buprenorphine Transdermal Patch Transdermal Drug Patches market, 2015 - 2026 (USD Million)
Figure Clonidine Transdermal Patch Transdermal Drug Patches market, 2015 - 2026 (USD Million)
Figure Oxybutynin Transdermal Patch Transdermal Drug Patches market, 2015 - 2026 (USD Million)
Figure Others Transdermal Drug Patches market, 2015 - 2026 (USD Million)
Figure Used for Hypertension market, 2015 - 2026 (USD Million)
Figure Used for Contraception market, 2015 - 2026 (USD Million)
Figure Used for Analgesia market, 2015 - 2026 (USD Million)
Figure Used for Smoking Cessation market, 2015 - 2026 (USD Million)
Figure Used for Angina market, 2015 - 2026 (USD Million)
Figure Used for Hormone Replacement market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Transdermal Drug Patches market, by country, 2015 - 2026 (USD Million)
-
Table North America Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table North America Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table North America Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Canada Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Canada Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Europe Transdermal Drug Patches market, by country, 2015 - 2026 (USD Million)
-
Table Europe Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Europe Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Europe Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Germany Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Germany Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table France Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table France Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Italy Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Italy Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Spain Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Spain Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal Drug Patches market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table China Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table China Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Japan Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Japan Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table India Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table India Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal Drug Patches market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table MEA Transdermal Drug Patches market, by country, 2015 - 2026 (USD Million)
-
Table MEA Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table MEA Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table MEA Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Transdermal Drug Patches market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Transdermal Drug Patches market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Transdermal Drug Patches market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Noven Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Agile Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hercon Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pocono Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Teikoku Pharma USA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Immune Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Xel Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table DURECT Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
